Season of Transitions
Three notable transitions worthy of reflection at this point in time.
The Underappreciated Value of New Product Planning
The value of New Product Planning (NPP) is often overlooked, but it plays a crucial role in the success of drug…
The Power of Target Product Profiles: Three Case Studies
In the biopharma industry, the Target Product Profile (TPP) is a critical tool for guiding the development and…
Unlocking Success: The Power of Target Product Profiles
In the ever-evolving biopharma landscape, success hinges not just on innovation but also on a clear roadmap guiding…
Your Biopharma Data Needs a Strategy
In the not-so-distant past, physician prescribing data was essentially a commodity with limited breadth or depth for…
Juggling Geographic Commercialization Priorities
Commercializing a pharmaceutical asset in one country is hard enough. Doing it on a global scale, with multiple country…
Communicating Without a Communications Leader
Many of our clients are emerging companies striving towards their first clinical development program in anticipation of…
Forecast Models: It’s Not All About the Numbers
What is the difference between strategic thinking in quantifying the future and Excel gymnastics? This was a…
Finding Partners in Biopharma: Standing Out in a Field of Many
When biopharma executives or business development leaders think about developing their “partnering story,” the focus is…
